Aardvark Therapeutics (AARD.US) Latest Stock News - Major News Analysis

Event Tracking

Dec3

BTIG and Raymond James Maintain and Initiate Buy Ratings for Aardvark Therapeutics

15:52

Nov14

Aardvark Therapeutics released FY2025 Q3 earnings on November 13 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.7514 (forecast USD -0.7533)

04:00

Aardvark Therapeutics released FY2025 9 Months earnings on November 13 (EST), actual revenue USD 0, actual EPS USD -2.1193

04:00

Oct9

Aardvark Therapeutics Secures FDA Approval to Expand Prader-Willi Syndrome Phase III Trial

10:06

Sep29

Analysts Upgrade Rating on Aardvark Therapeutics' ARD-101

08:41

Aug14

Aardvark Therapeutics released FY2025 Q2 earnings on August 13 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.6623 (forecast USD -0.59)

03:00